用于预测癌症化疗敏感性的非克隆性体外试验。 - Suppr | 超能文献

Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy.

作者信息

Weisenthal L M, Su Y Z, Duarte T E, Nagourney R A

机构信息

Veterans Administration Medical Center, Long Beach, CA.

出版信息

Prog Clin Biol Res. 1988;276:75-92.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy.用于预测癌症化疗敏感性的非克隆性体外试验。

Prog Clin Biol Res. 1988;276:75-92.

2

Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.通过前瞻性鉴定神经内分泌标志物和体外药敏试验为非小细胞肺癌患者制定个体化化疗方案。

Cancer Res. 1993 Nov 1;53(21):5181-7.

3

In vitro assays of chemotherapeutic sensitivity.化疗敏感性的体外测定

Important Adv Oncol. 1985:78-103.

4

[Reexamination of multimodal treatment in patient with cancer].[癌症患者多模式治疗的重新审视]

Gan To Kagaku Ryoho. 1994 Mar;21(4):555-7.

5

[Application of crossed assay design in test of drug sensitivity in vitro in combined chemotherapy of liver cancer].交叉试验设计在肝癌联合化疗体外药敏试验中的应用

Zhonghua Zhong Liu Za Zhi. 1993 Sep;15(5):378-80.

6

[In vitro drug sensitivity testing and chemotherapy of lung cancer].

Zhonghua Jie He He Hu Xi Za Zhi. 1993 Dec;16(6):345-6, 374.

7

[In vitro chemosensitivity assay using a double-layer-agar system: human tumor cloning assay and thymidine incorporation assay].[使用双层琼脂系统的体外化学敏感性测定：人肿瘤克隆测定和胸苷掺入测定]

Gan To Kagaku Ryoho. 1993 Mar;20(4):440-6.

8

Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.选择性细胞周期蛋白依赖性激酶2（cdc2）抑制剂丁内酯I对人肺癌细胞系的抗肿瘤作用。

Anticancer Res. 1996 Nov-Dec;16(6B):3387-95.

9

Evaluating response to antineoplastic drug combinations in tissue culture models.在组织培养模型中评估对抗肿瘤药物组合的反应。

Methods Mol Med. 2005;110:173-83. doi: 10.1385/1-59259-869-2:173.

10

Predictive tests for cancer chemotherapy and the problem of tumor cell heterogeneity.癌症化疗的预测性检测与肿瘤细胞异质性问题

Prog Clin Biol Res. 1988;276:119-37.

引用本文的文献

1

Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.功能检测在个体化癌症医学中的优势：不只是概念验证。

Theranostics. 2021 Sep 21;11(19):9538-9556. doi: 10.7150/thno.55954. eCollection 2021.

2

Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill.通过测量肿瘤细胞总杀伤率的体外耐药性检测指导非小细胞肺癌的化疗。

Br J Cancer. 1992 Jan;65(1):27-32. doi: 10.1038/bjc.1992.5.